Musaddiq Khan | VP, Customer Value - Digital Outcomes & TA Strategy
Medable

Musaddiq Khan has spent over 20 years in clinical research, starting with academic work on early lung cancer diagnosis before moving into industry roles at Parexel, Roche, and AstraZeneca, leading early-phase clinical programmes. After completing his Executive MBA at the University of Cambridge, where he focused on digital health strategy, he joined Eli Lilly to head clinical program operations and helped deliver the first-in-human study for their COVID-19 antibody programme.
Today, as Vice President for Therapeutic Area and Digital Outcomes Strategy at Medable, Musaddiq leads global efforts to integrate sensors, wearables, and digital tools into clinical development, shaping how technology transforms the future of healthcare.